<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039777</url>
  </required_header>
  <id_info>
    <org_study_id>17a1b</org_study_id>
    <nct_id>NCT03039777</nct_id>
  </id_info>
  <brief_title>Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients</brief_title>
  <official_title>Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New Jeddah Clinic Hospital</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemodialysis patients frequently develop catheter-related blood stream bacteremia (CRBSI).
      Procalcitonin is a marker of sepsis in bacterial infection. this study for detection of its
      role as a surrogacy marker in CRBSI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter-related blood stream bacteremia is common among hemodialysis patients. Clinically,
      fever and/or rigors with laboratory indicator of inflammation as leucocytosis and elevated
      c-reactive protein level are considered as markers for CRBSI before blood culture results
      became available.

      Procalcitonin is a valid indicator of sepsis. In this study, Procalcitonin level will be
      measured in any patient with suspected CRBSI and correlation will be tested for proved CRBSI
      by blood cultures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Actual">March 1, 2017</completion_date>
  <primary_completion_date type="Actual">February 28, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procalcitonin Level</measure>
    <time_frame>2 minutes after start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>Level of serum procalcitonin</description>
  </primary_outcome>
  <other_outcome>
    <measure>Blood culture (central and peripheral) results</measure>
    <time_frame>5 minutes after start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>Blood cultures organism growth results (positive/negative) confirming CRBSI</description>
  </other_outcome>
  <other_outcome>
    <measure>C Reactive Protein</measure>
    <time_frame>2 minutes after start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>Level of C reactive protein</description>
  </other_outcome>
  <other_outcome>
    <measure>erythrocyte sedimentation rate</measure>
    <time_frame>2 minutes after start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>erythrocyte sedimentation rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Urea Reduction Rate</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>Urea Reduction rate</description>
  </other_outcome>
  <other_outcome>
    <measure>creatinine</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>predialysis Serum creatinine</description>
  </other_outcome>
  <other_outcome>
    <measure>ferritin</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>predialysis Serum ferritin</description>
  </other_outcome>
  <other_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>Hemoglobin</description>
  </other_outcome>
  <other_outcome>
    <measure>potassium</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>predialysis serum potassium</description>
  </other_outcome>
  <other_outcome>
    <measure>Sodium</measure>
    <time_frame>up to 30 days prior to start of fever/chills or other symptoms suggesting CRBSI</time_frame>
    <description>predialysis serum sodium</description>
  </other_outcome>
  <enrollment type="Actual">28</enrollment>
  <condition>Hemodialysis Catheter Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hemodialysis patients with clinical signs of CRBSI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemodialysis patients with a dialysis catheter

          -  signs suggestive of CRBSI: fever/chills or leucocytosis with no other site of
             infection.

          -  Informed consent signed to be enrolled in the study

        Exclusion Criteria:

          -  Patient with identified cause of fever other than CRBSI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud H Imam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New jeddah clinic Hospital</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Mahmoud Hamada imam</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

